With recent advances in the treatments of blood cancers, UCLA Health and the Leukemia & Lymphoma Society are visiting communities across Southern California to discuss these emerging therapies.
Please join us online! Cancer patients, survivors and family members face unique stressors during the COVID-19 pandemic. Registration is required.
Cancer patients, survivors and family members face unique stressors during the COVID-19 pandemic. Please join us as we discuss strategies for managing fears and anxiety in this time of uncertainty.
Adolescents and young adults diagnosed with cancer share unique medical and psychological challenges. Join us at this dynamic panel to hear directly from blood cancer survivors diagnosed during their college years and the UCLA Health doctors and allied health professionals that provide care and support to these patients.
UCLA oncologist Monica Mead, MD, for an overview of treatment options for patients diagnosed with diffuse large B-cell lymphoma (DLBCL) and other follicular lymphomas. DLBCL is the most common type of non-Hodgkin lymphoma (NHL) in the US, accounting for about 1 out of every 3 lymphomas.
UCLA oncologist Joshua Sasine, MD, PhD, talks about the latest advancements in CAR T-cell therapy at UCLA.
UCLA oncologist Sarah Larson, MD, covers the latest treatment options and clinical trials available to patients with myeloma.
UCLA oncologist Herbert Eradat, MD, gives an overview of the latest advancements in immunotherapy and other treatments of blood cancers.
UCLA oncologists Gary Schiller, MD and Patricia Young, MD, and social worker Rebecca Pittenger, LCSW, give an overview of blood cancers, what causes them, symptoms and diagnosis. Our specialists cover the latest treatment options and clinical trials available to patients in a conversation moderated by Leila Evangelista from the Leukemia & Lymphoma Society.